Body weight gain frequently occurs during drug treatment of psychiatric disorders and is
often accompanied by increased appetite or food craving. While occurrence and time course …

Growing evidence suggests that the immune, endocrine, and nervous systems interact with
each other through cytokines, hormones, and neurotransmitters. The activation of the …

Introduction Antipsychotics (AP) induce weight gain. However, reviews and meta-analyses
generally are restricted to second generation antipsychotics (SGA) and do not stratify for …

One of the most widely used guides to prescribing psychiatric medications, the Tenth Edition
of Maudsley Prescribing Guidelines returns with fully updated content and new sections on …

Background While the incidence of new-onset diabetes mellitus may be increasing in
patients with schizophrenia treated with certain atypical antipsychotic agents, it remains …

Adverse metabolic effects, such as diabetes mellitus, lipid abnormalities and weight gain,
have increasingly been recognised with the use of the newer, so-called atypical …

Excessive body weight gain (BWG) is a common side effect of some typical and atypical
antipsychotic drugs (APs). Convergent evidence suggests a hierarchy in the magnitude of …

BackgroundWeight gain is a common consequence of antipsychotic drug treatment and can
lead to further morbidity. AimsTo assess the effects of antipsychotic drug therapy on …

Prescriptions for second-generation antipsychotics (SGAs) have surpassed those for first-
generation agents in the treatment of schizophrenia and bipolar disorder. While SGAs have …

Background: Weight gain is a common adverse effect associated with the use of most
antipsychotic drugs. Leptin has been reported to be associated with antipsychotic-induced …